Bulletin Updates

Evonik invests €25 million for MMP capacity expansion – 3 Feb 2023

Feb 03, 2023

As part of its ongoing efforts to fortify its extensive worldwide network of methionine manufacturing facilities, Evonik has spent €25 million in the development and expansion of its methyl mercapto-propionaldehyde (MMP) production plant in Germany.

Click details for more.

The full story is for subscribers. Log in to read it, or start a free trial.
Log in Start a free trial »